HOME > TOP STORIES

TOP STORIES

INTERVIEW CEO Weber Says Takeda’s Ongoing Transformation “Irreversible”: Full Interview

February 8, 2017
TRENDS Montelukast AG Achieves Rapid Market Penetration, Enjoys Stronger Start than Candesartan AG

February 7, 2017
BUSINESS Takeda Wants to Be Global GI Leader in 2025, Not in Acquisition Frenzy Mode: CEO

February 3, 2017
ORGANIZATION US Exclusion from Foreign Price Adjustment Should Be Carefully Considered: PhRMA Japan Chief

February 2, 2017
REGULATORY MHLW Pins Down Distribution Routes for Harvoni Counterfeits; Composition of Fake Pills Identified

February 1, 2017
BUSINESS Daiichi Sankyo Taps EVP Manabe as Next President

February 1, 2017
BUSINESS Major Products Face Impending Listing of Generics, though Patents Remain for Some

February 1, 2017
REGULATORY MHLW, Pharma Industry Officials Agree on Conditional Early Approval System

January 31, 2017
COMMENTARY Top-Notch Talents Needed for Pharma’s Lobbying Activities; Stay Current with Policymaking Moves

January 30, 2017
BUSINESS Daiichi Sankyo Espha to Launch Micardis AG, Will Actively Handle Competitors’ Products

January 27, 2017
REGULATORY MHLW Warns Against Purchasing Harvoni in Unpackaged Bottles

January 26, 2017
REGULATORY (Update) Chuikyo Agrees to Shed US Price from Foreign Price Adjustment Rule

January 25, 2017
REGULATORY Counterfeit Harvoni Found in Tokyo Too, Route Identified for a Nara Bottle

January 24, 2017
BUSINESS Ferring Speeding Up R&D in Core Sectors, Positive on Licensing and M&A: Japan CEO

January 23, 2017
ORGANIZATION JGA Head Frets Majority of Products Subject to Gap-Year Revisions Will Be Generics

January 20, 2017
BUSINESS Gilead Japan to Switch Sovaldi, Harvoni Bottles to Blister Packs

January 19, 2017
ORGANIZATION JMA’s Nakagawa Pushes Price Cuts Even on Non-100 Billion Yen Products, Eyes Other Hep C Drugs

January 18, 2017
REGULATORY Counterfeit Harvoni Discovered in Nara Pharmacy, MHLW Investigating Route of Entry into Distribution

January 18, 2017
REGULATORY MHLW to Ponder Additional Gap-Year Price Survey Method That Won’t Cripple Single-Product, Single-Price Efforts: Kanda

January 17, 2017
INTERVIEW MHLW’s Sakoi Calls on Industry to Transcend Corporate Boundaries, Join Pricing Reform Debate

January 16, 2017

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…